Topical CpG enhances the response of murine malignant melanoma to dacarbazine. [electronic resource]
Producer: 20080908Description: 2204-10 p. digitalISSN:- 1523-1747
- Adjuvants, Immunologic -- administration & dosage
- Administration, Topical
- Animals
- Antineoplastic Agents, Alkylating -- administration & dosage
- Apoptosis -- drug effects
- CD4-Positive T-Lymphocytes -- pathology
- CD8-Positive T-Lymphocytes -- pathology
- Cell Line, Tumor
- Dacarbazine -- administration & dosage
- Disease Models, Animal
- Drug Therapy, Combination
- Injections, Intraperitoneal
- Melanoma -- drug therapy
- Mice
- Mice, Inbred C57BL
- Oligodeoxyribonucleotides -- administration & dosage
- Skin Neoplasms -- drug therapy
- T-Lymphocytes, Cytotoxic -- pathology
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.